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Environmental air pollution is an aggravating 
event for sudden unexpected death in epilepsy 
Exposição ambiental à poluição do ar é um evento agravante para a  
ocorrência de morte súbita nas epilepsias
Carla A. Scorza1, Lineu Calderazzo1, Ricardo M. Arida2, Esper A. Cavalheiro1, Fulvio A. Scorza1
Epilepsy is the most common serious neurological con-
dition that has no geographic, social, or racial boundaries; 
it occurs in men and women and affects people of all ages, 
although it more frequently affects young people in the first 
two decades of life and people over the age of 60 years1,2. It is 
a chronic disease, and several factors negatively impact the 
quality of life in people with epilepsy1. Thus, there is general 
agreement that stigma and exclusion are common features 
of epilepsy in developed countries and in developing coun-
tries1,3. Epilepsy furthermore often has profound physical, 
psychological, and social consequences since seizures may 
cause misunderstanding, fear, secrecy, stigmatization, and 
social isolation1,3. Despite all aforementioned features, the no-
tion persists that epilepsy is a benign condition in which in-
dividuals only have seizures. Thus, it is pertinent to mention 
that epilepsy is a malignant condition that has a high rate of 
premature death, compared to the death rate in the general 
population4–6. By this reasoning, sudden unexpected death in 
epilepsy (SUDEP) is probably the most common cause of epi­
lepsy-related deaths4,5,7. The term SUDEP is used when sud-
den death occurs in an otherwise reasonably healthy person 
with epilepsy and the autopsy examination does not reveal 
a toxicological or anatomical cause of death4,8. Sudden unex­
pected death in epilepsy is epidemiologically responsible for 
7.5% to 17% of all deaths in people with epilepsy and has an 
incidence between 1:500 and 1:1000 patient­years among 
adults9. There is a significant body of literature suggesting the 
risk factors for SUDEP are the presence of or experiencing 
numerous generalized tonic­clonic seizures (GTCS), noctur-
nal seizures, young age at epilepsy onset, longer duration of 
1Disciplina de Neurologia Experimental, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo SP, Brasil;
2Departamento de Fisiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo SP, Brasil.
Correspondence: Fulvio A. Scorza; Rua Botucatu 862 / Edifício Leal Prado; 04023-900 São Paulo SP - Brasil; E-mail: scorza.nexp@epm.br
Financial support: This study received the following grants: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Conselho Nacional de 
Desenvolvimento Científico e Tecnológico (CNPq); FAPESP/Fundação de Amparo à Pesquisa do estado de Minas Gerais (FAPEMIG); FAPESP/PRONEX; and 
FAPESP/CNPq/MCT (Instituto Nacional de Neurociência Translacional).
Conflict of interest: There is no conflict of interest to declare.
Received 28 March 2013; Received in final form 19 April 2013; Accepted 06 May 2013.
ABSTRACT
It is extremely difficult to estimate the occurrence of sudden unexpected death in epilepsy (SUDEP). On the other hand, discovering and 
carefully evaluating new risk factors that may contribute to the onset of cardiovascular abnormalities in people with refractory epilepsy may 
prevent fatal events in these individuals. In this context, we should not ignore that urban air pollution is a leading problem for environmen-
tal health and is able to cause serious cardiovascular dysfunctions that culminate in sudden death. In this regard, we aimed to determine 
whether environmental exposure to air pollution is an aggravating event for SUDEP.
Keywords: air pollution, epilepsy, heart, omega-3, sudden death. 
RESUMO
É extremamente difícil estimar a ocorrência de morte súbita em epilepsia (SUDEP). Por outro lado, detectar e avaliar cuidadosamente novos 
factores de risco que podem contribuir para o aparecimento de alterações cardiovasculares em pessoas com epilepsia refratária poderá 
ser capaz de impedir a ocorrência de eventos fatais nestes indivíduos. Neste contexto, não devemos negligenciar hoje que a poluição do ar 
nas grandes cidades é um problema para a saúde ambiental, podendo causar graves disfunções cardiovasculares, que culminam em morte 
súbita. Neste sentido, propusemos nesse trabalho que a exposição ambiental a poluição do ar é um evento agravante para a ocorrência de 
SUDEP.
Palavras-chave: coração, epilepsia, morte súbita, ômega-3, poluição do ar. 
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epilepsy, dementia, absence of cerebrovascular disease, asthma, 
male gender, symptomatic etiology of epilepsy, and alcohol 
abuse4,10–14. 
Several predisposing and initiating factors may coexist 
and contribute to SUDEP; however, the exact causal mecha-
nisms are poorly understood. Experimental and clinical stu-
dies suggest that major autonomic dysfunction (i.e. respi-
ratory and cardiovascular abnormalities during and a fter 
seizures) seems to have a major role in SUDEP4,15–17. Ac -
cording to the mechanisms already proposed, it is well re-
ported that the final events that may lead to SUDEP are a 
postictal central nervous system shutdown with pronounced 
EEG suppression, ictal or postictal apnea, and ictal cardiac 
arrhythmia4,16–18. 
It is unfortunately extremely difficult to estimate SUDEP. 
On the other hand, discovering and carefully evaluating new 
risk factors that may contribute to the onset of cardiovas-
cular abnormalities in people with refractory epilepsy may 
prevent fatal events in these individuals. In this context, we 
should not ignore that urban air pollution is nowadays a 
leading problem for environmental health; it is able to cause 
serious cardiovascular dysfunctions that culminate in sud-
den death19,20. In this regard, would it be plausible to asso-
ciate environmental exposure to air pollution as an aggrava­
ting event for SUDEP? Because of the information mentioned 
so far, it would be appropriate to consider that the answer to 
this question is true.
Our planet is being endangered by a capitalist society in 
which social injustice is based on a thorough environmen-
tal injustice. In this regard, the presence of solid or liquid 
particles in the air, which is called particulate matter (PM), 
has grown exponentially in modern capitalist societies. The 
big cities are areas that produce large quantities of PM that 
originate in traffic and from buildings and industries loca­
ted on the perimeters of the cities. Thus, several epidemio-
logic stu dies have demonstrated that even low levels of expo-
sure to air pollution contribute to the onset and aggravation 
of cardiovascular diseases, thereby increasing the rates of 
morbidity and mortality20. For that purpose, nine years ago 
the American Heart Association published its first scienti­
fic statement regarding PM air pollution and cardiovascu-
lar di sease21. The purpose of this statement was to provide 
healthcare professionals and regulatory agencies with a com-
prehensive review of the literature linking PM air pollution 
exposure with cardiovascular morbidity and mortality21. In 
the final section, the experts unanimously concluded that 
exposure to PM air pollution contributes to acute cardio-
vascular morbi dity and mortality, and is therefore able to re-
duce life expectancy by a few years21. After this first scientific 
statement, se veral studies were conducted focusing on the 
cardiovascular changes that occur with exposure to PM air 
pollution. In this way, some interesting results should be pre-
sented to demons trate the importance of the topic posted in 
this paper. For example, the American Cancer Society (ACS), 
as part of the Cancer Prevention II study, demonstrated an 
increased risk for death by ischemic heart disease associa­
ted with longterm exposure to elevated levels of fine parti-
cles of less than 2.5 µm (PM2.5) (in aerodynamic diameter)
22. 
Ischemic cardiac events accounted for the largest relative 
risk (RR, 1.18; 95%CI 1.14­1.23) and absolute risk for mor-
tality per 10 µg/m3 elevation in PM2.5
22.  The ACS study also 
found that deaths because of arrhythmias, heart failure, and 
car diac arrest (RR, 1.13; 95%CI 1.05­1.21 per 10 µg/m3) were 
also associated with prolonged exposure to PM2.5
22. Other 
studies have shown that exposure to elevated PM2.5 levels 
resulting from vehicular traffic in urban areas may exacer-
bate the risk of myocardial infarction in susceptible peo-
ple23–25. In a United States Medicare study, Dominic26 and 
colleagues reported that short-term exposure to PM2.5 in-
creases the risk of hospital admissions for cardiovascular 
and respiratory di seases. They furthermore showed that a 
10­µg/m3 reduction in PM2.5 would reduce
 the number of 
annual hospita lizations for heart failure in 204 urban coun-
ties by 1,523 cases per year26.
In addition, other studies demonstrate an association of 
air pollution ( fine PM and related pollutants) with the in-
creased incidence of ventricular tachyarrhythmias (as re-
corded by implanted cardioverter defibrillators)27–29. From 
the data presented so far, although the mechanisms are not 
well understood, PM­induced cardiovascular abnormalities 
are believed to involve inflammation and oxidative stress 
initiated by the formation of reactive oxygen species (ROS) 
within affected cells30,31.
After the presentation of these exciting results by the 
scientific community over these nine years, the American 
Heart Association published in 2010 an excellent updated 
scientific statement to provide a comprehensive review of 
the new evidence linking PM exposure with cardiovascular 
disease, with a specific focus on highlighting the clinical im-
plications for researchers and healthcare providers32. In brief, 
the research team acknowledges that—although the existing 
evidence supports a direct causal relationship between ex-
posure to elevated PM2.5 levels and cardiovascular mortali­
ty – continued research is important in areas of controversy 
and uncertainty to further understand the full nature of this 
issue32. In this sense, the scientists encourage the examina-
tion of whether certain treatment modalities (such as supple-
mentation with omega­3) will be associated with significant 
reduced cardiac stress that is caused by exposure to elevated 
PM2.5 levels
32. 
This dietary perspective began in 2008 with the elegant 
work by Romieu and colleagues, which was the first study 
to examine the effects of omega­3 on the biomarkers of the 
cellular response to the oxidative stress of air pollution33. In 
brief, they recruited residents from a nursing home in Mexico 
City who chronically exposed to particulates of 2.5 µg or 
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less in aerodynamic diameter and followed them for seven 
months. In a double­blind fashion, the authors randomly as-
signed the residents to receive either fish oil (containing the 
omega­3 polyunsaturated fatty acid [PUFA]) or soy oil. They 
afterwards measured the indoor PM2.5 levels in the nursing 
home, and measured the biomarkers of the response to oxi-
dative stimuli [copper/zinc (Cu/Zn) superoxide dismutase 
(SOD) activity, lipoperoxidation (LPO) products, and reduced 
glutathione (GSH) level], and they evaluated the impact of 
supplementation on plasma levels of these biomar kers33. 
They found that supplementation with either fish oil or soy 
oil was correlated with an increase of Cu/Zn SOD activity 
and an increase in GSH plasma levels, whereas exposure to 
indoor PM2.5 levels was correlated with a decrease in Cu/Zn 
SOD activity and GSH plasma levels33. On the whole, the au-
thors concluded that supplementation with either fish oil or 
soy oil was correlated with an increase of Cu/Zn SOD acti­
vity and an increase in GSH plasma levels, whereas exposure 
to indoor PM2.5 levels was correlated with a decrease in Cu/
Zn SOD activity and GSH plasma levels; this suggests that 
omega­3 PUFA intake could modulate oxidative response to 
PM2.5 exposure
33.
These data inspired us as neuroscientists to develop the 
following question: would people with epilepsy around the 
world benefit from this therapeutic approach since they 
are also exposed to PM air pollution? The answer is twofold 
positive!
First, through experimental and clinical studies, our re-
search group is quite convinced that omega­3 fatty acids 
are very important for the normal functioning of the brain 
and are useful in preventing and/or treating epilepsy34–36. 
Furthermore, these studies encourage researchers to seek a 
new possibility for use of omega­3 in epilepsy, based on their 
possible action in reducing SUDEP. In this sense, since ome-
ga­3 fatty acids per se have been shown to reduce cardiac ar-
rhythmias and sudden cardiac deaths, it would be plausible 
to propose that supplementation with this polyunsaturated 
fatty acid in people with refractory seizures may reduce sei-
zures and seizure­associated cardiac arrhythmias, and hence 
reduce SUDEP37,38.
From all information in this new proposal, what is the 
best way to proceed forward? Most capitalist countries al-
ready have strict antipollution legislation that requires cer-
tain factories to have special equipment ( filters, waste 
treat ment, etc.) or to use less polluting processes. In these 
countries, there is also intense control on pollution caused 
by exhaust from automotive vehicles. These procedures 
achieve significant results, although they do not completely 
eliminate the problem of air pollution. A greater awareness of 
the population would be quite feasible. It would meanwhile 
be very important to assess carefully the precautionary re­
commendations described by leaders of the American Heart 
Association32. These researchers claim that, although some 
clinical recommendations have not been clinically tested or 
proven to reduce mortality, they are practical and feasible 
measures that may help to reduce exposure to air pollution 
and therefore potentially lower the associated cardiovascular 
risk32. Following this line of reasoning, epileptologists must 
keep in mind that air pollution is a serious problem for the 
general population, including for individuals with epilepsy. 
Therefore, it would be interesting to be knowledgeable of 
American Heart Association recommendations32, to try to 
improve the quality of life of people with epilepsy around the 
world, and (most importantly) to decrease the risk of cardio-
vascular abnormalities and SUDEP in people with epilepsy 
who are at high risk for these outcomes.
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